Volume 26, 2022 Library PDF

This archive contains the following articles listed by volume, issue and page number:

Issues Included
Issue/Volume	Title
January/February 2022 Vol. 26 No. 1	Volume 26, Number 1
March/April 2022 Vol. 26 No. 2	Volume 26, Number 2
May/June 2022 Vol. 26 No. 3	Volume 26, Number 3
July/August 2022 Vol. 26 No. 4	Volume 26, Number 4
September/October 2022 Vol. 26 No. 5	Volume 26, Number 5
November/December 2022 Vol. 26 No. 6	Volume 26, Number 6

Volume 26, 2022 Articles

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2022 Pg. 4	PreScription: IJPC--Starting Year 26 Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 6-8	Compounded Melatonin Cream for the Prevention and Treatment of Radiation Dermatitis: A Case Report Author(s): Garcia-Segura Laura Corral, Garcia-Segura Javier Corral, Delgado Carlos Dorado, Maldonaldo Nuria Romero, Salgado Elena Cardero, Llorens Lucía Pérez
Jan/Feb 2022 Pg. 10-17	Pharmacy Student Satisfaction and Perceptions Following a Virtual Sterile Compounding Experience Author(s): Mohammad Insaf, Lobkovich Alison, Nardolillo Joseph, Wilhelm Shelia
Jan/Feb 2022 Pg. 18-23	A Compendium of Compounding Agents and Formulations, Part 1: Melatonin Author(s): Riepl Mike
Jan/Feb 2022 Pg. 24-28	Editorial: Should All Pharmacists Compound? Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 30-32	Everything Old is New Again Author(s): Brunner Scott
Jan/Feb 2022 Pg. 34-38	Basics: Considerations and Background Information for Counseling Patients Using Compounded Suppositories Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 41-49	Sterile Basics: Compounding Sterile Preparations with Cyclodextrins Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 50	Calculations Author(s): Stockton Shelly J
Jan/Feb 2022 Pg. 52	Aluminum Chloride 6.25% in Anhydrous Alcohol Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 53	Ascorbic Acid 10% in Anhydrous PEG ointment Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 54	Deoxyarbutin 3% Anhydrous Emulsion Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 55	Diclofenac Sodium 1%-15% Topical Gel Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 56	Enalapril Maleate 1 mg-mL in Ora-Plus and Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 57	Mometasone Furoate 0.1% Lotion Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 58-64	Capsule Machine Validation Author(s): Al-Achi Antoine, McGreggor Tysheon, Jaligama Shreelekha, Friday Kafi, Alyami Hussain
Jan/Feb 2022 Pg. 65-71	Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management Author(s): Hong Eun Ji, Sumanasekera Wasana, Le Uyen Minh
Jan/Feb 2022 Pg. 72-79	Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint) Author(s): Soefje Scott, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
Jan/Feb 2022 Pg. 80-87	Investigation of the Effects of Excipients in the Compounding of Amlodipine Besylate Orally Disintegrating Tablets Author(s): Azmi Nurual Hanisah Saiful, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai
Mar/Apr 2022 Pg. 92	PreScription: Comments on the FDA Guidance "Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry" Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 94-98	A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin Author(s): Riepl Mike
Mar/Apr 2022 Pg. 100-109	Allowing Compounding Pharmacies to Address Drug Shortages Author(s): Broughel James
Mar/Apr 2022 Pg. 110-115	The Potential Effects of a Compounded Methylcobalamin Nasal Spray on Short-term Memory Loss After Intracranial Hemorrhage: A Case Report Author(s): Good Lauren, Lieu Yi, Banov Fabiana, Harger Beau, Banov Daniel
Mar/Apr 2022 Pg. 116-117	Quality Control: Photodocumentation in Pharmacy Compounding Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 118-126	Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 129-136	Sterile Basics of Compounding: Methods of Sterilization and Depyrogenation Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 138	Calculations Author(s): Stockton Shelly J
Mar/Apr 2022 Pg. 140	Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 141	Codeine Phosphate 3 mg/mL in Ora-Sweet Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 142	Ketoconazole 2%, Terbenafine 1%, Acetic Acid 2%, and Urea 2% in Dimethyl Sulfoxide Nail Polish Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 143	Lorazepam 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 144	Mesalamine 100-mg/mL Suspension Enema Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 145	Naproxen 25 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 146	Phenobarbital 10 mg/mL in SyrSpend SF pH4, Cherry Flavored Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 147	Phenytoin 15 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 148	Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 149	Pyridoxine Hydrochloride 50 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 150-154	Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates) Author(s): Brandin Thibaut, Wasilewski Maya, Panuccio Camille, Bouguergour Cyrielle, Primas Nicolas, Lamy Edouard, Jean Christophe, Bertault-Peres Pierre, Rathelot Pascal, Curti Christophe, Vanelle Patrice
Mar/Apr 2022 Pg. 155-162	Comparison of Solvent Casting and Spray Casting Method on Compounding of an Orally Disintegrating Film Containing Amlodipine Besylate Author(s): Ruslan Mohamad Fariz Haiqal, Janakiraman Ashok Kumar, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai
Mar/Apr 2022 Pg. 163-174	Molding as Innovative Technology for Personalized Tablet Production Author(s): Mady Omar Y, Al-Shoubki Adam A, Hagag Youssef, Ibrahim Bakry, Donia Ahmed A
May/Jun 2022 Pg. 180	PreScription: Standing in the Gap Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 182-186	Art of Pharmacy v. State Author(s): Standridge Rob
May/Jun 2022 Pg. 189-193	A Compendium of Compounding Agents and Formulations, Part 3: Gentamicin Sulfate and Benzoyl Peroxide Author(s): Riepl Mike
May/Jun 2022 Pg. 195-200	A Procedure for Tablet Production by Using the 3D Molding Technology and Powder Micromeritics Properties Author(s): Mady Omar
May/Jun 2022 Pg. 201-209	Compounding for Investigational and Clinical Studies Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 211-213	Three Things You Need to Know Right Now Author(s): Brunner Scott
May/Jun 2022 Pg. 214-217	Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 219-228	Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 230	Calculations Author(s): Stockton Shelly J
May/Jun 2022 Pg. 232	Alendronate Sodium 1% Topical Dental Gel Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 233	Azstarys in Ora-Blend Single Dose Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 234	Candesartan Cilexitil 1 mg/mL Syrup Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 235	Chloral Hydrate 70 mg/mL Syrup Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 236	Cinnarizine 1 mg/mL in Oral Medium-Chain Triglycerides Anhydrous Vehicle Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 237	Clobazam 1 mg/mL in Oral-Mix Suspension Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 238	Metronidazole 7.5 mg/mL Topical Oil-in-Water Microemulsion Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 239	Nitrazepam 1 mg/mL Oral Solution Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 240	Sirolimus 0.1% Ointment Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 241	Valganciclovir 20 mg/mL in Ora-Plus and Ora-Sweet Suspension Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 242-247	Finding the Right Balance: A Nationwide Study of Student Pharmacist Exposure to and Perceptions of Nonsterile Compounding Author(s): Fredrickson Mary E, Belcher Faith G, Del Vecchio Kamryn N, Galleher Miranda N, Jugo Leila S, Gothard M David, Pallotta Raneem H, Pallotta Victor A Jr
May/Jun 2022 Pg. 248-254	Physical and Chemical Stability of Pharmaceutical Preparation of Bumetanide and Scopolamine Author(s): Catry Emilie, Colsoul Marie-Louise, Closset Melanie, Hubert Justine, Soumoy Laura, Bihin Benoit, Thiry Emmanuell, Jamart Jacques, Hecq Jean-Daniel, Galanti Laurence
May/Jun 2022 Pg. 255-263	Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets Author(s): Liew Kai Bin, Hii Shou Hui, Chew Yik Ling, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam
Jul/Aug 2022 Pg. 268	PreScription: Pharmacy and Drug Information Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 270-274	A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline Author(s): Riepl Mike
Jul/Aug 2022 Pg. 277-281	Compounding with Pracaxi Versus Copaiba Oil Author(s): Magutu Tom
Jul/Aug 2022 Pg. 283-291	Evaluation of the Physical-chemical Characteristics and Biopharmaceutical Performance of Dilu-Cap: A Complete Line of Excipients for Hard-shell Capsules Author(s): de Oliveira Ferreira Anderson, Polonini Hudson
Jul/Aug 2022 Pg. 293-296	Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases Author(s): Harrington Amy, Williams LaVonn
Jul/Aug 2022 Pg. 298-301	The Role of Compounding Pharmacists During Drug Shortages Author(s): Ofei Kelvin
Jul/Aug 2022 Pg. 302-307	Basics: Hollow-type Suppositories Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 309-315	Sterile Basics of Compounding: How to Implement a Robust Visual-inspection Program Author(s): Summers Amy
Jul/Aug 2022 Pg. 316	Calculations Author(s): Stockton Shelly J
Jul/Aug 2022 Pg. 318	Betamethasone Dipropionate 0.05% and Salicylic Acid 3% Lotion Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 319	Cetrimide Lotion Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 320	Dexamethasone 1 mg/mL in Oral Mix Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 321-322	Furosemide 5-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 323-324	Hydralazine Hydrochloride 10 mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 325-326	Indomethacin 1% Topical Gel Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 327	Nystatin 250,000-unit Frozen Popsicles Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 328	Povidone Iodine 100-mg/mL Solution/Spray Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 329	Psoriasis Topical Ointment Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 330-335	Physicochemical and Microbiological Stability of Vancomycin 10-mg/mL Intravitreal Syringes Author(s): Bartoll Aaron Puplà, Bellés Medall Maria Dolores, Peñarrocha Josep Edo, Escrig Laura Solaz, Clemente Ruben Eguren, Azuara Julia Bodega, Piqueres Raul Ferrando
Jul/Aug 2022 Pg. 336-341	Long-term Stability of Epitheliotropic Factors in Frozen Serum Eye Drops Author(s): Sahyoun Jean-Yves, Cloutier Marc, Frenette Mathieu, Robert Marie-Claude
Jul/Aug 2022 Pg. 342-351	Physicochemical and Microbiological Stability of Amitriptyline Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
Sep/Oct 2022 Pg. 356	PreScription: A New Dosage Form Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 358-362	Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration Author(s): Lopez C Vidal, Rios GL Quito
Sep/Oct 2022 Pg. 364-368	A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans Author(s): Riepl Mike
Sep/Oct 2022 Pg. 370-377	Recent Formulation Advances and Preparation of Orally Disintegrating Tablets Author(s): Ejeta Fikadu
Sep/Oct 2022 Pg. 378-384	Compounded Medications and Probiotics for Irritable Bowel Syndrome Author(s): Narváez Katherine Rivera, Thompson Tara
Sep/Oct 2022 Pg. 385-395	Compounding with Biotechnology Products, Part 1: General Considerations Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 396-398	The FDA is in a Hole. It Should Stop Digging. Author(s): Brunner Scott
Sep/Oct 2022 Pg. 400-408	Basics of Compounding: Compounding with Microneedle Arrays, Part 1: Introduction and Overview Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 411-418	Sterile Basics of Compounding: Contamination Control Strategies, Part 1 Author(s): Summers Amy
Sep/Oct 2022 Pg. 420	Calculations Author(s): Stockton Shelly J
Sep/Oct 2022 Pg. 422	Amphotericin B 3% Otic Gel Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 423	Ascorbic acid 5% Topical Microemulsion Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 424	Chlorhexidine Diacetate 2% Topical Gel Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 425	Clindamycin Hydrochloride 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 426	Clotrimazole 10-mg Troches Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 427	Cysteamine Hydrochloride 100 mg/mL Oral Solution Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 428	Hydrogen Peroxide 1.5% with Sodium Fluoride 0.5-mg/mL Oral Rinse Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 429	Lansoprazole 3-mg/mL in Ora-Blend Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 430	Metronidazole 10%, Nifedipine 0.5%, Lidocaine 1.5%, and Diclofenac 3% Ointment Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 431	Methylcobalamin 2-mg/mL Nasal Spray Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 432-435	Effectiveness of a New Ultraviolet C Disinfection System to Inactivate Airborne Coronavirus in Different Environmental Conditions Author(s): Marianni Bruna, Polonini Hudson
Sep/Oct 2022 Pg. 436-439	Effects of Calcium Polystyrene Sulfonate Formulation Change from Dry Syrup to Oral Solution in Patients with Chronic Kidney Disease Author(s): Kobayashi Shunsuke, Ogawara Yuka, Imamura Yoshihiko, Kitaoka Akira, Yasu Takeo
Nov/Dec 2022 Pg. 444	PreScription: Compounded Drugs Often Become Manufactured Drugs Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 446-466	Compounding with Biotechnology Products, Part 2: Product-specific Considerations Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 468-472	Unlicensed Transdermal Medications in Feline Patients: Three Case Reports Author(s): Urwin Craig, Jean Linda, Carvalho Maria, Robson-Laws Michael
Nov/Dec 2022 Pg. 474-479	Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies Author(s): Maham Nicole Y
Nov/Dec 2022 Pg. 480-488	A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing Author(s): Riepl Mike
Nov/Dec 2022 Pg. 490-495	Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 497-504	Sterile Basics of Compounding: Contamination Control Strategies, Part 2 Author(s): Summers Amy
Nov/Dec 2022 Pg. 506	Calculations Author(s): Stockton Shelly J
Nov/Dec 2022 Pg. 508	Bacitracin 0.01% and Phenol 0.1% in Cetaphil Lotion Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 509	Curcumin 2% Topical Gel Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 510	Diazoxide 10-mg/mL in Oral Mix SF Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 511	Enrofloxacin 11.35 mg/mL in Ora-Blend, Veterinary Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 512	Flucytosine 50 mg/mL in Oral-Sweet and Ora-Plus Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 513	Granisetron Hydrochloride 005 mg/mL in Ora-Sweet and Ora-Plus Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 514	Miller's Modified Mouthwash Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 515	Potassium Alum 1% Bladder Irrigation for Hemorrhagic Cystitis (Low-Medium Risk Compounding) Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 516-521	Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage Author(s): Kumaravelrajan Rajagopal, Karthik B, Venkatasan Suba
Nov/Dec 2022 Pg. 522-526	Intravenous Physical Compatibility of Heparin Sodium and Furosemide Author(s): Maktabi Briana, Howard Mitchell S, Baki Gabriella, Churchwell Mariann D